Influence of obesity on blood glucose control using continuous glucose monitoring data among patients with type 1 diabetes

被引:0
|
作者
Nicolau, Joana [1 ]
Romano, Andrea [1 ]
Rodriguez, Irene [1 ]
Sanchis, Pilar [1 ]
Puga, Maria [1 ]
Masmiquel, Lluis [1 ]
机构
[1] Hosp Son Llatzer, Inst Invest Sanitaria Illes Balears IdISBa, Dept Endocrinol & Nutr, Ctra Manacor Km 4, Palma De Mallorca 07198, Baleares, Spain
来源
ENDOCRINOLOGIA DIABETES Y NUTRICION | 2024年 / 71卷 / 05期
关键词
Type; 1; diabetes; Overweight; Obesity; Continuous glucose monitoring; BODY-MASS INDEX; OVERWEIGHT; CHILDHOOD; DISEASE; CANCER;
D O I
暂无
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Introduction: The global increase in the prevalence rates of overweight or obesity has also affected patients with type 1 diabetes (T1D), where this disease had traditionally been associated with a lean phenotype. On the other hand, the effect of obesity on new glycemic control metrics obtained from continuous glucose monitoring (CGM) in T1D is poorly understood. We wanted to assess whether there is any relationship between BMI (body mass index) and the different CGM metrics or HbA1c. Methods: Two hundred and twenty-five patients with T1D (47.1% female, mean age 42.9 +/- 14.7 years) with a CGM for a minimum of 6 months were analysed by downloading their CGM and collecting clinical and anthropometric variables. Results: 35.1% (79/225) of the T1D patients had overweight and 17.3% (39/225) lived with obesity, while the remaining 47.6% had a normal weight. A negative correlation was found between GMI (glucose management indicator) and BMI (-0.2; p = 0.008) and HbA1c (-0.2; p = 0.01). In contrast, a positive correlation was observed between the total dose of insulin and the BMI (0.3; p < 0.0001). No significant correlations were found between BMI and other CGM metrics. Conclusions: Overweight or obesity do not imply worse glycemic control in patients with T1D or less use of CGM. Possibly, and in order to achieve a good glycemic control, more units of insulin are necessary in these patients which, in turn, makes weight control more difficult. (c) 2024 SEEN y SED. Published by Elsevier Espana, S.L.U. All rights reserved.
引用
收藏
页码:202 / 207
页数:6
相关论文
共 50 条
  • [21] Continuous glucose monitoring: effect on glucose control and treatment satisfaction in diabetes mellitus type 1
    Langeland, L. L.
    Salvesen, O.
    Selle, H.
    Carlsen, S. M.
    Fougner, K. J.
    DIABETOLOGIA, 2010, 53
  • [22] Efficacy and safety comparison of continuous glucose monitoring and self-monitoring of blood glucose in type 1 diabetes
    Wojciechowski, Piotr
    Rys, Przemyslaw
    Lipowska, Anna
    Gaweska, Magdalena
    Malecki, Maciej T.
    POLSKIE ARCHIWUM MEDYCYNY WEWNETRZNEJ-POLISH ARCHIVES OF INTERNAL MEDICINE, 2011, 121 (10): : 333 - 343
  • [23] Continuous glucose monitoring for 5 days using a novel glucose-electrode in patients with Type 1 diabetes
    Heinemann, L
    Ravel, K
    Kronshage, B
    Nosek, L
    Heise, T
    Kapitza, C
    Ward, K
    Sass, D
    Essenpreis, M
    Voelkel, D
    Lodwig, V
    DIABETOLOGIA, 2004, 47 : A308 - A308
  • [24] HOW PATIENTS WITH TYPE 1 DIABETES TRANSLATE CONTINUOUS GLUCOSE MONITORING DATA INTO DIABETES MANAGEMENT DECISIONS
    Pettus, Jeremy
    Price, David A.
    Edelman, Steven V.
    ENDOCRINE PRACTICE, 2015, 21 (06) : 613 - 620
  • [25] Doctors recommend continuous glucose monitoring for patients with type 1 diabetes
    McCarthy, Michael
    BMJ-BRITISH MEDICAL JOURNAL, 2016, 354
  • [26] Continuous glucose monitoring can benefit patients with type 1 diabetes
    Wise, Jacqui
    BMJ-BRITISH MEDICAL JOURNAL, 2017, 356
  • [27] Variation in Utilization of Continuous Glucose Monitoring in Patients with Type 1 Diabetes
    Lacy, Mary E.
    Fowlkes, John
    Heier, Kory
    Sohn, Min-Woong
    Kruse-Diehr, Aaron J.
    Waters, Teresa
    Moga, Daniela C.
    DIABETES, 2023, 72
  • [28] Continuous Glucose Monitoring vs. Capillary Blood Glucose in Hospitalized Type 2 Diabetes Patients
    Verissimo, David
    Vinhais, Joana
    Ivo, Catarina
    Martins, Ana Claudia
    Nunes e Silva, Joao
    Passos, Dolores
    Castro, Joao Jacome
    Lopes, Luis
    Marcelino, Mafalda
    CUREUS JOURNAL OF MEDICAL SCIENCE, 2023, 15 (08)
  • [29] Professional Continuous Glucose Monitoring Improves Glucose Control in Type 2 Diabetes
    Leibowitz, Jonas
    Wisotsky, Daniel J.
    DIABETES, 2019, 68
  • [30] Empagliflozin decreases glucose exposure and variability in patients with type 1 diabetes: continuous glucose monitoring data (EASE-1)
    Kaspers, S.
    Famulla, S.
    Pieber, T. R.
    Eilbracht, J.
    Neubacher, D.
    Soleymanlou, N.
    Broedl, U. C.
    DIABETOLOGIA, 2015, 58 : S367 - S367